ArticleCancers2025

Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients.

Noa Shani Shrem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.